These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2936799)

  • 1. Neuronal nuclear membrane indentation and astrocyte/neuron ratio in Huntington's disease. A quantitative electron microscopic study.
    Roos RA; Bots GT; Hermans J
    J Hirnforsch; 1985; 26(6):689-93. PubMed ID: 2936799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of morphological features in Huntington's disease.
    Roos RA; Bots GT; Hermans J
    Acta Neurol Scand; 1986 Feb; 73(2):131-5. PubMed ID: 2939683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological changes of the nucleus accumbens in Huntington's chorea.
    Bots GT; Bruyn GW
    Acta Neuropathol; 1981; 55(1):21-2. PubMed ID: 6215820
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear membrane indentations in Huntington's chorea.
    Roos RA; Bots GT
    J Neurol Sci; 1983 Sep; 61(1):37-47. PubMed ID: 6226764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
    Ma L; Nicholson LF
    Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasynaptic corpora amylacea in the striatum.
    Averback P
    Arch Pathol Lab Med; 1981 Jun; 105(6):334-5. PubMed ID: 6453566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain.
    Curtis MA; Penney EB; Pearson J; Dragunow M; Connor B; Faull RL
    Neuroscience; 2005; 132(3):777-88. PubMed ID: 15837138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization.
    Ferrante RJ; Kowall NW; Cipolloni PB; Storey E; Beal MF
    Exp Neurol; 1993 Jan; 119(1):46-71. PubMed ID: 8432351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytometrical and immunocytochemical investigation of brain nuclei in dementia.
    Dom R; Lammens M; Saedeleer JD; Hauman H
    Prog Clin Biol Res; 1989; 317():375-81. PubMed ID: 2602424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.
    Hirano M; Iritani S; Fujishiro H; Torii Y; Habuchi C; Sekiguchi H; Yoshida M; Ozaki N
    Neuropathology; 2019 Oct; 39(5):331-341. PubMed ID: 31264738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated astrocytes display increased 5-HT2a receptor expression in pathological states.
    Wu C; Singh SK; Dias P; Kumar S; Mann DM
    Exp Neurol; 1999 Aug; 158(2):529-33. PubMed ID: 10415157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for progression in frontal cortical pathology in late-stage Huntington's disease.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    J Comp Neurol; 2004 Jan; 468(2):190-204. PubMed ID: 14648679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease.
    Bando Y; Onuki R; Katayama T; Manabe T; Kudo T; Taira K; Tohyama M
    Neurochem Int; 2005 Jan; 46(1):11-8. PubMed ID: 15567511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia.
    Kreczmanski P; Heinsen H; Mantua V; Woltersdorf F; Masson T; Ulfig N; Schmidt-Kastner R; Korr H; Steinbusch HW; Hof PR; Schmitz C
    Brain; 2007 Mar; 130(Pt 3):678-92. PubMed ID: 17303593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.